Klenner; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klenner; Thomas.The latest application filed is for "indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties".

Company Profile

0.7.6

Klenner; Thomas - Ingelheim DE
Klenner, Thomas - Ingeiheirn DE
Klenner; Thomas - Hellenthal DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties Grant 7,452,910 - Nickel , et al. November 18, 2	2008-11-18
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties App 20080057124 - Nickel; Bernd ; et al.	2008-03-06
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties App 20040171668 - Nickel, Bernd ; et al.	2004-09-02
Use of dopamine receptor antagonists in palliative tumor therapy Grant 6,696,428 - Nickel , et al. February 24, 2	2004-02-24
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties Grant 6,693,119 - Nickel , et al. February 17, 2	2004-02-17
2-acyl indole derivatives and their use as antitumor agents App 20030158216 - Beckers, Thomas ; et al.	2003-08-21
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties App 20030114511 - Nickel, Bernd ; et al.	2003-06-19
Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis Grant 6,544,551 - Engel , et al. April 8, 2	2003-04-08
Use of dopamine receptor antagonists in palliative tumor therapy App 20030008846 - Nickel, Bernd ; et al.	2003-01-09
2-acyl indole derivatives and their use as antitumor agents App 20020091124 - Beckers, Thomas ; et al.	2002-07-11
Xanthone compounds, their preparation and use as medicament Grant 6,403,636 - Reutrakul , et al. June 11, 2	2002-06-11
Adaptor for connecting a chip card to a computer slot Grant 6,272,017 - Klatt , et al. August 7, 2	2001-08-07
Tumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugs Grant 5,837,462 - Beckers , et al. November 17, 1	1998-11-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.